Abstract -Aims: Tolerance to ethanol-induced inhibition of N-methyl-D-aspartate receptors (NMDARs) is thought to underlie the acute adaptive mechanisms against ethanol. To explore these compensatory upregulating mechanisms of NMDARs, we investigated the expression and phosphorylation of NMDAR subunits in vivo following an acute ethanol treatment. Methods: Male SpragueDawley rats were given 4 g/kg ethanol, and the phospho-S896-NR1, NR2A and NR2B subunits of NMDAR were immunoblotted from the cerebral cortex and hippocampus. We also examined the mRNAs and ubiquitinated forms of the NR2A and NR2B subunits. Results: Acute ethanol treatment increased phospho-S896-NR1 at 30 min in the cerebral cortex and hippocampus, and the increase was maintained until 2 h in the hippocampus. Ethanol increased total NR2A and NR2B expression at 30 min in the cortex and hippocampus, and the NR2A increase was maintained until 2 h in the hippocampus. The increased expression of the NR2A and NR2B subunits was not associated with statistically significant alterations in mRNA expression or protein ubiquitination. Conclusion: Acute ethanol treatment increased NR1 subunit phosphorylation and NR2A and NR2B subunit expression in the cerebral cortex and hippocampus of rats. These effects of ethanol on the NMDAR subunits may underlie the mechanisms that compensate for ethanol-induced inhibition of NMDARs. However, the regulation of NR2A and NR2B in this paradigm is not dependent on transcriptional changes.
INTRODUCTION
Ethanol affects various neurotransmitter receptors such as dopamine, γ-amino butyric acid A (GABA A ), glycine and glutamate receptors (Nagy, 2008) . Among these, N-methyl-D-aspartate-type glutamate receptors (NMDARs) are closely related to the action of ethanol (Wirkner et al., 1999; Woodward, 2000) . Ethanol is a potent and selective inhibitor of NMDARs (Dildy and Leslie, 1989; Hoffman et al., 1989; Lovinger et al., 1989; Lovinger, 1993) . Because glutamate is a comprehensive and potent excitatory neurotransmitter, the ethanol-induced inhibition of NMDARs is thought to underlie the acute behavioral effects of ethanol, i.e. motor-skill impairment and sedation. These behavioral effects depend upon blood ethanol concentration (BEC). Interestingly, the BEC threshold for the same motor-skill impairment differs between the ascending and descending phase of the BEC curve following ethanol administration (Schweizer and Vogel-Sprott, 2008) . Even under the same BEC, motor impairment is more prominent when BEC is on the rise (i.e. while drinking) than when BEC is decreasing (i.e. after the completion of drinking). This adaptive phenomenon is known as acute ethanol tolerance, which occurs 5-60 min after ethanol administration (Khanna et al., 1980 (Khanna et al., , 1991 (Khanna et al., , 1992 , suggesting a compensatory mechanism against the acute effects of ethanol.
Although the cellular mechanisms of this adaptive reaction against acute ethanol exposure are not well-known, these mechanisms are related to several neurotransmitters such as glutamate, GABA and serotonin (Khanna et al., 1980; Allan and Harris, 1987; Reynolds and Brien, 1994) . In particular, NMDARs are an important target for developing acute ethanol tolerance (Khanna et al., 2002; Lin et al., 2003 Lin et al., , 2006 . Acute tolerance to ethanol-induced inhibition of NMDAR functions has been reported in both in vitro and in vivo studies. NMDA-induced depolarization in sympathetic preganglion neurons (Lin et al., 2003) and the pressor responses after NMDA administration to the medulla (Lin et al., 2006) are attenuated over time during continuous ethanol treatment. Some studies have reported that the regulating mechanisms of NMDARs attenuating ethanol-induced inhibition of NMDAR functions, such as Fyn tyrosine kinase (Miyakawa et al., 1997; Yaka et al., 2003; Hsieh et al., 2009; Wang et al., 2010) , Src tyrosine kinase (Hsieh et al., 2009) protein kinase A (Leonard and Hell, 1997; Hsieh et al., 2009) and protein kinase C (Leonard and Hell, 1997; Tingley et al., 1997) mediate acute tolerance by NMDAR subunit phosphorylation. Nevertheless, the precise mechanisms of the interaction between ethanol and NMDARs in terms of acute compensatory mechanisms against ethanol exposure have not been established.
Extensive studies have demonstrated the relationships between chronic exposure to ethanol and NMDARs. Chronic exposure to ethanol induces differential compensatory upregulation of the expression of various NMDAR subunits, which is thought to be linked to ethanol tolerance, dependence and withdrawal symptoms (Nagy et al., 2005) . Several reports have demonstrated that NMDAR subunit expression, including NR1 (Trevisan et al., 1994; Kalluri et al., 1998; Qiang et al., 2006) , NR2A (Kalluri et al., 1998) and NR2B (Kalluri et al., 1998; Henniger et al., 2003; Qiang et al., 2006) , in the cerebral cortex and hippocampus of rats or mice are upregulated following chronic ethanol treatment. These increases in NMDAR protein subunit expression are associated with augmented mRNA expression (Darstein et al., 2000; Roberto et al., 2006) . Although some investigators have suggested that the acute and chronic tolerance mechanisms are distinct (Khanna et al., 1992; Draski et al., 2001) , it is unclear whether the regulation of NMDA receptor-mediated signaling by acute ethanol treatment is mediated by mechanisms similar to those of chronic ethanol treatment. To address this issue, we investigated whether an acute ethanol treatment is associated with the upregulation of protein expression and NMDAR subunit phosphorylation in the rat cerebral cortex and hippocampus. We also investigated whether the protein expression of NMDAR subunits is regulated by mRNA expression or protein degradation.
METHODS

Animals and experimental protocol
Animals were treated in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Ethanol [Merck, Whitehouse Station, NJ, USA, cat. #1.00983.1011; 4 g/kg, diluted to 20% (w/v) in normal saline] was injected intraperitoneally into male Sprague-Dawley rats (150-200 g). Control animals were treated precisely in the same way, but normal saline was injected. The rats were decapitated at 30 min and at 2, 6 and 24 h after injection. To reduce the number of animals used, more animals were allocated to the times when an acute effect was expected, i.e. 30 min and 2 h. Our pilot study indicated that BEC dropped to zero at 6 h after ethanol administration. The cerebral cortex and the hippocampus were rapidly dissected on ice, immediately frozen in liquid nitrogen, and stored at −70°C until analysis.
Blood ethanol concentration
Blood samples were drawn from some animals when they were decapitated to determine the BEC. Serum was separated from the samples and stored at −20°C until analysis. An Ethanol Assay kit (DIET-500, BioAssay Systems, Hayward, CA, USA) was used to determine BEC.
Immunoblotting
Frozen tissue was homogenized in 10 w/v ice-cold radioimmunoprecipitation assay (+) buffer, as described previously (Kang et al., 2006) . The lysates were centrifuged at 20 000g for 10 min to create supernatants. These samples contained both membrane and soluble fractions. When we separately prepared the membrane and soluble fractions, we found that both NR2A and NR2B subunits existed exclusively in the membrane fraction regardless of ethanol treatment (data not shown); so, we assumed that the total fraction used represented membrane-bound NR2A and NR2B subunits.
Protein concentrations in the supernatants were determined using the Bradford protein assay (Bradford, 1976) . The supernatants were boiled with Laemmli's sample buffer. Equal amounts of protein were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes. The membranes were incubated with primary antibodies specific to NR1 (1:1000; Upstate, Billerica, MA, USA, cat. #05-432), phospho-S896-NR1 (1:2000; Cell Signaling Technology, Danvers, MA, USA, cat. #3384s), NR2A (1:1000; Cell Signaling Technology, cat. #4205s), NR2B (1:1000; Cell Signaling Technology, cat. #4207s) or β-actin (1:5000; Sigma-Aldrich, St. Louis, MO, USA, cat. #A5441) followed by incubation with peroxidase-labeled secondary antibody. Then, the membranes were developed using the Enhanced Chemiluminescence System (Pierce, Rockford, IL, USA).
The specificity of the phospho-S896-NR1 antibody was validated with lamda phosphatase treatment (data not shown).
Immunoprecipitation
Frozen tissue was homogenized in 10 w/v ice-cold lysis buffer [50 mM Tris ( pH 7.4), 150 mM NaCl, 0.2 mM Np40, 4 mM ethylene glycol tetraacetic acid ( pH 8.0), 10 mM ethylene diamine tetraacetic acid ( pH 8.0), 15 mM sodium pyrophosphate, 40 mM NaF, 1 mM Na 3 VO 4 , 100 mM β-glycerophosphate, 1 mM phenylmethanesulfonylfluoride, 1 mM dithiothreitol, Complete Mini Protease Inhibitor Cocktail; Roche Diagnostics, Basel, Switzerland]. The lysates were centrifuged at 20 000g for 20 min to create supernatants. Protein concentrations in the supernatants were determined using the Bradford protein assay. Supernatants containing 1 mg of total protein were incubated with antibody specific to ubiquitin (Santa Cruz Biotechnology, Heidelberg, Germany, cat. #sc-8017) overnight at 4°C, followed by a 4 h incubation with protein A/G-beads (Santa Cruz Biotechnology, cat. #sc-2003) . The immunoprecipitate was washed five times with lysis buffer. After centrifugation at 20 000g for 2 min, the precipitate was boiled with 2 × Laemmli's buffer and subjected to SDS-PAGE. The amounts of NR2A and NR2B in the immunoprecipitates were then detected by immunoblotting.
Real-time reverse transcription PCR
Real-time reverse transcription PCR was performed to detect NR2A and NR2B mRNA expression in rat cerebral cortex and hippocampus. RNA was isolated using TRI reagent (Molecular Research Center, Inc., Cincinnati, OH, USA, cat. #TR-118). mRNA was reverse-transcribed into cDNA using SuperScipt II (Invitrogen, Carlsbad, CA, USA, cat. #18064-014), with 1 µg of total RNA sample as the template. Real-time reverse transcription PCR was performed by SYBR-Green-based amplification detection using an ABI7000 Real-time PCR Detection System (Applied Biosystems, Carlsbad, CA, USA). After the initial treatment at 50°C for 2 min followed by 95°C for 10 min, 40 cycles were conducted, with denaturation for 15 s at 95°C and annealing and elongation for 1 min at 60°C. A thermalstability analysis was performed to confirm amplification of a single PCR product. Primers to NR2A (forward, 5 0 -CCT CGA ACC CTT CAG TGC CT-5 0 ; reverse, 5 0 -AAT GGC TGA GAC GAT GAG CAG-5 0 ), NR2B (forward, 5 0 -TCT GCC TTC TTA GAG CCA TTC AG-3 0 ; reverse, 3 0 -AGA CAG CCA CCG CAG AAA C-3 0 ) and β-actin (forward, 3 0 -GCT ATC ACT ATT GGC AAC GA-3 0 ; reverse, 3 0 -AGC CAT GCC AAT GTT GTC TC-3 0 ) were used.
Statistical analyses
Immunoblotting and immunoprecipitation signal intensities were quantified with a densitometer using Tina program ver. 2.10 g (Raytest, Straubenhardt, Germany). The signal intensity of the protein bands was normalized using the β-actin signal intensity. mRNA expression was quantified by calculating the difference between the cycle threshold of the mRNA of interest and β-actin for each sample. Data were statistically analyzed using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). A two-way analysis of variance (ANOVA) was performed to examine time and treatment effects of ethanol on protein expression and phosphorylation, mRNA expression and ubiquitination of the NMDAR subunits. Data were further analyzed using a post hoc Tukey's test when a significant time or treatment effect was found. The level of significance was set at 0.05.
RESULTS
Blood ethanol concentrations
The BEC was 38.5 ± 1.7 mM (mean ± SEM) at 30 min and 17.2 ± 1.6 mM at 2 h (Fig. 1) . The BEC was barely detectable at 6 (1.7 ± 1.8 mM) and 24 h (2.2 ± 2.1 mM). The BEC at 30 min was within a clinically relevant concentration of 25-100 mM.
Protein expression and S896 phosphorylation of NR1 subunits Cortex In a two-way ANOVA, the ethanol treatment and time effects on protein expression of NR1 were not significant (df = 3, F = 0.286, P = 0.835) in rat cortex. However, the ethanol treatment effect on phospho-S896-NR1 was significant (df = 1, F = 21.586, P = 0.000), whereas the time effect was not (df = 1, F = 1.450, P = 0.239).
S896-NR1 phosphorylation increased up to 221% that of the control 30 min after the ethanol treatment ( post hoc Tukey's test, df = 14, P = 0.000, compared with the vehicle treatment; Fig. 2 ). The S896 phosphorylation differences between the ethanol and control groups disappeared at 2 h ( post hoc Tukey's test, df = 14, P = 0.207; Fig. 2) . No difference was found between the two groups at 6 and 24 h.
Hippocampus
In a two-way ANOVA, the ethanol treatment and time effects on the protein expression of NR1 were not significant (df = 3, F = 2.834, P = 0.056) in rat hippocampus. However, the ethanol treatment and time effects on phospho-S896-NR1
were both significant (df = 1, F = 38.389, P = 0.000; df = 1, F = 9.181, P = 0.005, respectively), and the treatment × time interaction was also significant (df = 1, F = 8.103, P = 0.008). These data suggest that the treatment effect was more significant than the time effect, and this difference seemed to be related to animal handling. S896-NR1 phosphorylation increased up to 324% that of the control 30 min after the ethanol treatment ( post hoc Tukey's test, df = 14, P = 0.000 compared with the vehicle treatment; Fig. 2 ), and at 2 h, it was still 187% that of the control, which was statistically significant ( post hoc Tukey's test, df = 14, P = 0.019; Fig. 2 ). S896 phosphorylation levels in the ethanol and control groups were not different at 6 and 24 h.
NR2A and NR2B subunit protein expression Cortex In a two-way ANOVA, the time effect of protein expression was not significant for either the NR2A (df = 1, F = 0.779, P = 0.385) or NR2B subunits (df = 1, F = 0.702, P = 0.409) in the rat cortex. However, the treatment effect of protein expression was significant for both NR2A (df = 1, F = 27.047, P = 0.000) and NR2B (df = 1, F = 12.809, P = 0.001).
NR2A protein expression increased to 186% that of the control 30 min after ethanol treatment ( post hoc Tukey's test, df = 32, P = 0.002; Fig. 3) . At 2 h, NR2A expression was 140% that of the control, but the statistical significance disappeared ( post hoc Tukey's test, df = 32, P = 0.204; Fig. 3 ).
NR2B protein expression increased to 147% that of the control at 30 min after the ethanol treatment ( post hoc Tukey's test, df = 32, P = 0.004; Fig. 3) . At 2 h, NR2B expression was 134% that of the control, but the statistical significance disappeared ( post hoc Tukey's test, df = 32, P = 0.146; Fig. 3) .
No difference in NR2A or NR2B expression was observed between the ethanol and control groups at 6 and 24 h after the ethanol treatment.
In a two-way ANOVA, the time effect was not significant for either NR2A (df = 1, F = 2.567, P = 0.120) or NR2B (df = 1, F = 0.117, P = 0.735) in rat hippocampus. However, the treatment effect was significant for both NR2A (df = 1, F = 30.036, P = 0.000) and NR2B (df = 1, F = 12.868, P = 0.001).
NR2A protein expression increased to 168% that of the control 30 min after the ethanol treatment ( post hoc Tukey's test, df = 32, P = 0.003; Fig. 3 ). NR2A expression was 163% that of the control at 2 h, and the statistical significance was maintained ( post hoc Tukey's test, df = 32, P = 0.002; Fig. 3) NR2B protein expression increased up to 137% that of the control at 30 min after the ethanol treatment ( post hoc Tukey's test, df = 32, P = 0.003; Fig. 3 ). NR2B expression was 114% that of the control at 2 h, but the statistical significance disappeared ( post hoc Tukey's test, df = 32, P = 0.345; Fig. 3) .
No difference in NR2A or NR2B expression was observed between the ethanol and control groups at 6 and 24 h after the ethanol treatment. NR2A and NR2B subunit mRNA expression Because NR2A and NR2B protein expression after ethanol treatment was more robust at 30 min and 2 h, we examined NR2A and NR2B mRNA expression at those intervals. NR2A and NR2B mRNA expression was normalized to that of β-actin. In a two-way ANOVA, neither the time effect nor the treatment effect was statistically significant. A t-test of NR2A mRNA expression between the ethanol and control groups revealed no differences at 30 min and 2 h in cortex (df = 6, P = 0.905; df = 6, P = 0.698, respectively) or in hippocampus (df = 6, P = 0.872; df = 6, P = 0.576, respectively) (Fig. 4) . NR2B mRNA expression also showed no difference at 30 min and 2 h in cortex (df = 6, P = 0.310; df = 6, P = 0.703, respectively) or hippocampus (df = 6, P = 0.932; df = 6, P = 0.200, respectively) (Fig. 4) .
NR2A and NR2B subunit protein ubiquitination
Because a corresponding increase in NR2A and NR2B mRNA expression was not observed with protein expression, we examined whether ethanol treatment affected protein degradation by NR2A and NR2B ubiquitination.
In a two-way ANOVA, neither the time effect nor the treatment effect was statistically significant. A t-test for protein ubiquitination of the NR2A subunit between the ethanol and control groups showed no difference at 30 min and 2 h in cortex (df = 16, P = 0.920; df = 16, P = 0.864, respectively) or hippocampus (df = 16, P = 0.207; df = 16, P = 0.576, respectively) (Fig. 5) . Protein ubiquitination of the NR2B subunit also showed no difference at 30 min and 2 h in cortex (df = 16, P = 0.324; df = 16, P = 0.952, respectively) and hippocampus (df = 16, P = 0.260; df = 16, P = 0.679, respectively) (Fig. 5) . In the hippocampus, NR2A and NR2B protein ubiquitination decreased to 75% that of the control at 30 min. However, these changes were not statistically significant for either NR2A or NR2B.
DISCUSSION
Regulation of NMDAR-mediated signaling by ethanol has been studied mainly as a chronic treatment, which serves as Fig. 2 . Protein expression and S896 phosphorylation of the NMDA receptor NR1 subunit in rat cortex and hippocampus following acute ethanol administration The ethanol and control groups were administered ethanol (4 g/kg) and normal saline, respectively. Rats were decapitated at 30 min and at 2, 6 and 24 h after treatment. Eight independent sets of animals were used for each experiment. Total and S896-phosphorylated NR1 subunits were detected using immunoblotting. Data are expressed as the mean and SEM of the relative optical density (OD) from eight independent experiments. Data were analyzed using a two-way ANOVA to examine time and treatment effects on the phosphorylation and amounts of protein following the control and ethanol treatments. Data were further analyzed using post hoc Tukey's tests when a significant treatment effect was found. Asterisks indicate statistically significant differences in the ODs of the ethanol group at each time compared with those of the control group (Tukey's test; *P < 0.05, **P < 0.001). Error bars represent SEMs. a model for the tolerance and withdrawal of patients with ethanol dependence. Chronic exposure to ethanol induces upregulation and phosphorylation of NMDAR subunits. In the present study, we demonstrated that acute exposure to ethanol also induced increases in NR2A and NR2B subunit protein expression and increased NR1 subunit phosphorylation in rat brain. Upregulation and phosphorylation of NMDAR subunits caused by chronic ethanol exposure are a compensatory reaction to ethanol-induced NMDAR inhibition (Nagy et al., 2005; Nagy, 2008) . Similarly, the upregulation and phosphorylation of NMDAR subunits may lead to recovery of NMDAR functional activity under the acute effect of ethanol. This effect subsided when ethanol was cleared from the blood. These alterations may contribute to acute ethanol tolerance. Most studies have reported that acute ethanol tolerance occurs over the time course of 5-60 min following ethanol administration (Khanna et al., 1991 (Khanna et al., , 1992 . In this study, alterations in NMDAR subunits were detected at 30 min after ethanol administration and decreased thereafter. Although we did not measure the behavioral effects of ethanol to determine acute tolerance, the alterations in the NMDAR subunits occurred within the time course of acute tolerance. Moreover, these alterations corresponded to the BECs, suggesting that augmented NMDAR function antagonizes the acute effect of ethanol. Compared with the increases in NR1, NR2A and NR2B subunits during chronic exposure, only increases in NR2A and NR2B subunits were observed after an acute exposure in the present study. The NR2A subunit showed a more robust increase than did the NR2B subunit in both the cortex and hippocampus, and the NR2A and NR2B subunits showed a greater increase in the cortex than in the hippocampus. It has been suggested that receptor subunit composition may influence the sensitivity of the NMDAR to ethanol (Dingledine et al., 1999; Jin et al., 2008) . Among the several subunits of NMDAR (NR1, NR2A-2D, NR3A and NR3B), the majority of studies have focused on the role of the NR2 subunits to regulate ethanol sensitivity to NMDAR, although NR1 splice variants and NR3A subunits have received attention recently (Jin and Woodward, 2006; Jin et al., 2008) . NR1/NR2 heteromers containing either NR2A or NR2B subunits are more susceptible to the effect of ethanol than are heteromers containing NR2C or NR2D (Kuner et al., 1993; Masood et al., 1994) . This higher sensitivity of NR2A and NR2B to ethanol may lead to an enhanced cellular response to ethanol when NR2A or NR2B subunit expression increases. Thus, functional augmentation of NMDAR through the increase in heteromers containing the NR2A and NR2B subunits may play a role in canceling out the effect of acute ethanol exposure.
Chronic and acute ethanol exposure results in similar upregulation of the NR2A and NR2B subunits. However, because the regulation by acute ethanol exposure is only transient, the mechanisms of upregulation seem to be distinct for acute and chronic exposure. During chronic ethanol exposure, increased NR2A and NR2B subunit protein expression is accompanied by increased mRNA expression of the subunits (Darstein et al., 2000; Floyd Roberto et al., 2006) . In contrast, acute ethanol exposure did not increase NR2A and NR2B subunit mRNA expression in the present study. Acute ethanol exposure tended to decrease the NR2A and NR2B subunit ubiquitination in the hippocampus. However, the decrease was neither robust nor statistically significant and seemed unable to account for the large increase in protein expression. Therefore, regulation through gene transcription is not related to upregulation and regulation through protein stability and is not a major mechanism in the upregulation of NR2A and NR2B subunits after acute ethanol treatment. Some authors have reported no corresponding mRNA increase with the protein increase of the NMDAR subunits in rat brain even after chronic ethanol exposure (Snell et al., 1996) . Another regulatory mechanism of NMDAR subunits, i.e. a microRNA (miRNA) mechanism, may contribute to the increase in subunit expression without corresponding mRNA expression. As miRNAs alter mRNA transcript stability (Denli and Hannon, 2003) , they may contribute to increased expression of the NR2A and NR2B subunits. Although no evidence demonstrates a relationship between miRNAs and NMDAR expression, a previous report suggested that ethanol induces or suppresses expression of miRNAs (Sathyan et al., 2007) . Recently, Miranda et al. (2010) critically reviewed ethanol-sensitive miRNAs as a regulatory master switch of the pleiotropic effects of ethanol, including the development of tolerance. Further investigation of this issue is needed.
Phosphorylation is the most frequent post-translational modification regulating protein activity. In our results, acute ethanol treatment seemed to regulate NMDAR activity through the NR1 subunit phosphorylation at S896, whereas chronic ethanol treatment regulates NMDAR activity through NR1 subunit protein expression (Floyd et al., 2003) . Regulating NMDAR activity through acute treatment requires more rapid regulatory mechanisms, such as phosphorylation. S896 is on the C1 cassette of the NR1 subunit. The C1 cassette regulates export of NR1 from the endoplasmic reticulum and forward trafficking to the synapse (Rosenblum et al., 1997; Nagy, 2008) . Although recent NR1 mutation studies have suggested that S896 phosphorylation may not contribute to the acute ethanol sensitivity of NMDARs (Xu and Woodward, 2006; Xu et al., 2010) , S896 phosphorylation of the NR1 subunit may modulate NMDA receptor trafficking and clustering (Llansola et al., 2005) . S896 phosphorylation increases trafficking to the NR1 subunit membrane in fibroblasts (Tingley et al., 1997) , whereas phosphorylated S896 is not found in the membrane of cultured cerebellar neurons (Sanchez-Perez and Felipo, 2005) . In our study, the phosphorylated S896 NR1 subunit was detected only in the membrane fraction and not in the soluble fraction (data not shown), suggesting an increase in NR1 membrane trafficking by S896 phosphorylation in vivo. Consequently, ethanol may enhance NMDAR function through NR1 translocation into the synapse following NR1 phosphorylation. This may also be related to the compensatory mechanisms against ethanol-induced NMDAR inhibition. In conclusion, our results indicate that acute ethanol administration differentially induces NMDAR subunit expression and phosphorylation in vivo. Acute administration of ethanol induces NR2A and NR2B subunit expression and NR1 subunit phosphorylation of NMDAR in rat cortex and hippocampus. The increased NR2A and NR2B subunit expression was not associated with increased mRNA expression, and decreased ubquitination-degradation was not sufficient to explain the increases. Further studies are required to establish the functional relationship between NMDAR expression and phosphorylation and acute ethanol tolerance, and to elucidate the possible role of miRNA in NR2A and NR2B subunit regulation.
Funding -This work was supported by a grant from Korea Tomorrow and Global, Korea.
